This study revealed that Cynarine could significantly reduce the fat deposition ability of NAFLD model cells, which may be closely related to the effective regulation of AKT1 and MAPK1 expression by Cynarine. Here, AKT1 is linked to metabolic dysfunction-associated steatotic liver disease.